Does anti-IL-5 deplete bronchial mucosal eosinophils in mild atopic asthma?

被引：0
作者：
Flood-Page, P
Menzies-Gow, A
Compton, C
Walls, C
Barnes, N
Robinson, DS
Kay, AB
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, NHLI Div, London, England
[2] GSK, Harlow, Essex, England
[3] London Chest Hosp, London E2 9JX, England
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2002年 / 109卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：743 / 743
页数：1
相关论文
共 50 条
[21]   Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab [J].
Suzaki, Isao ;
Kimura, Yurika ;
Tanaka, Akihiko ;
Hirano, Kojiro ;
Ishibashi, Atsushi ;
Mizuyoshi, Tomomi ;
Ando, Izumi ;
Kitajima, Tatsuya ;
Watanabe, So ;
Hinohira, Yasuyuki ;
Kobayashi, Hitome .
AURIS NASUS LARYNX, 2019, 46 (01) :141-146
[22]   Anti-IL-5 and anti-IL-5R biologics for severe asthma. Are there any differences in their effects? [J].
Granda, Paula ;
Villamanan, Elena ;
Carpio, Carlos ;
Laorden, Daniel ;
Quirce, Santiago ;
alvarez-Sala, Rodolfo .
JOURNAL OF ASTHMA, 2024, 61 (08) :857-866
[23]   Effectiveness of anti-IgE and anti-IL-5 treatment in step 5 asthma patients. [J].
Saji, Junko ;
Muraoka, Hiromi ;
Nishimoto, Eriko ;
Matsuzawa, Shin ;
Okamoto, Mariko ;
Inoue, Teppei ;
Handa, Hiroshi ;
Nishine, Hiroki ;
Inoue, Takeo ;
Miyazawa, Teruomi ;
Mineshita, Masamichi .
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[24]   Bronchodilator Responsiveness Does Not Help Determine Anti-IL-5 Targeted Biologic Success in Patients With Severe Asthma [J].
Zhao, Wei ;
Hogan, Mary Beth .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (12) :3184-3185
[25]   Anti-IL-5 biologics carve out severe-asthma niche [J].
Dolgin, Elie .
NATURE BIOTECHNOLOGY, 2014, 32 (11) :1075-1076
[26]   Anti-IL-5 treatments in severe eosinophilic asthma: real life datas [J].
Ozdel Ozturk, Betul ;
Bavbek, Sevim .
TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2020, 68 (02) :148-159
[27]   Anti-IL-5 biologics carve out severe-asthma niche [J].
Elie Dolgin .
Nature Biotechnology, 2014, 32 :1075-1076
[28]   Anti-IL-5 therapy and DRESS [J].
Khan, Sujoy .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (09) :941-941
[29]   Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis [J].
Oldhoff, JM ;
Darsow, U ;
Werfel, T ;
Katzer, K ;
Wulf, A ;
Laifaoui, J ;
Hijnen, DJ ;
Plötz, S ;
Knol, EF ;
Kapp, A ;
Bruijnzeel-Koomen, CAFM ;
Ring, J ;
de Bruin-Weller, MS .
ALLERGY, 2005, 60 (05) :693-696
[30]   A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma [J].
Busse, William W. ;
Ring, Johannes ;
Huss-Marp, Johannes ;
Kahn, Jean-Emmanuel .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (04) :803-813
12345